Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Steven Leeder

Showing results (41-50 of 191) with videos related to

Pageof 20
Sort By:
Clinical Pharmacology and Therapeutics|November 16, 2023
Response to "What is the Current Clinical Impact of the CYP2C:TG Haplotype?"Pablo Zubiaur, J Steven Leeder, Francisco Abad-Santos, et al.
Pediatric Research|June 29, 2010
Selective Toll--like receptor expression in human fetal lungJoshua E Petrikin, Roger Gaedigk, J Steven Leeder, et al.
Seminars in Fetal & Neonatal Medicine|February 11, 2005
Ontogeny of drug metabolizing enzymes in the neonateMichael J Blake, Lisa Castro, J Steven Leeder, et al.
Clinical Pharmacology and Therapeutics|December 20, 2023
Population Pharmacokinetic Analysis of Atomoxetine and its Metabolites in Children and Adolescents with Attention-Deficit/Hyperactivity DisorderShen Cheng, Mahmoud Al-Kofahi, J Steven Leeder, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 18, 2006
CYP2D6*36 gene arrangements within the cyp2d6 locus: association of CYP2D6*36 with poor metabolizer statusAndrea Gaedigk, L Dianne Bradford, Sarah W Alander, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 17, 2016
Dynamics of Cytosine Methylation in the Proximal Promoters of CYP3A4 and CYP3A7 in Pediatric and Prenatal LiversCarrie A Vyhlidal, Chengpeng Bi, Shui Qing Ye, et al.
Clinical Pharmacology and Therapeutics|August 2, 2002
Unique CYP2D6 activity distribution and genotype-phenotype discordance in black AmericansAndrea Gaedigk, L DiAnne Bradford, Kenda A Marcucci, et al.
Pharmacogenetics and Genomics|March 9, 2018
PharmGKB summary: clobazam pathway, pharmacokineticsRachel Huddart, J Steven Leeder, Russ B Altman, et al.
British Journal of Clinical Pharmacology|May 5, 2017
Aprepitant and fosaprepitant drug interactions: a systematic reviewPriya Patel, J Steven Leeder, Micheline Piquette-Miller, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 25, 2022
Isolation and Identification of 3,4-Seco-Solanidine-3,4-dioic acid (SSDA) as a Urinary Biomarker of Cytochrome P450 2D6 (CYP2D6) ActivityAndrew C Behrle, Justin Douglas, J Steven Leeder, et al.
Pageof 20

Showing results (41-50 of 191) with videos related to

Sort By:
Pageof 20
Clinical Pharmacology and Therapeutics|November 16, 2023
Response to "What is the Current Clinical Impact of the CYP2C:TG Haplotype?"Pablo Zubiaur, J Steven Leeder, Francisco Abad-Santos, et al.
Pediatric Research|June 29, 2010
Selective Toll--like receptor expression in human fetal lungJoshua E Petrikin, Roger Gaedigk, J Steven Leeder, et al.
Seminars in Fetal & Neonatal Medicine|February 11, 2005
Ontogeny of drug metabolizing enzymes in the neonateMichael J Blake, Lisa Castro, J Steven Leeder, et al.
Clinical Pharmacology and Therapeutics|December 20, 2023
Population Pharmacokinetic Analysis of Atomoxetine and its Metabolites in Children and Adolescents with Attention-Deficit/Hyperactivity DisorderShen Cheng, Mahmoud Al-Kofahi, J Steven Leeder, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 18, 2006
CYP2D6*36 gene arrangements within the cyp2d6 locus: association of CYP2D6*36 with poor metabolizer statusAndrea Gaedigk, L Dianne Bradford, Sarah W Alander, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 17, 2016
Dynamics of Cytosine Methylation in the Proximal Promoters of CYP3A4 and CYP3A7 in Pediatric and Prenatal LiversCarrie A Vyhlidal, Chengpeng Bi, Shui Qing Ye, et al.
Clinical Pharmacology and Therapeutics|August 2, 2002
Unique CYP2D6 activity distribution and genotype-phenotype discordance in black AmericansAndrea Gaedigk, L DiAnne Bradford, Kenda A Marcucci, et al.
Pharmacogenetics and Genomics|March 9, 2018
PharmGKB summary: clobazam pathway, pharmacokineticsRachel Huddart, J Steven Leeder, Russ B Altman, et al.
British Journal of Clinical Pharmacology|May 5, 2017
Aprepitant and fosaprepitant drug interactions: a systematic reviewPriya Patel, J Steven Leeder, Micheline Piquette-Miller, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 25, 2022
Isolation and Identification of 3,4-Seco-Solanidine-3,4-dioic acid (SSDA) as a Urinary Biomarker of Cytochrome P450 2D6 (CYP2D6) ActivityAndrew C Behrle, Justin Douglas, J Steven Leeder, et al.
Pageof 20